Screener
Prime Medicine PRME Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
FAQ
- What is Prime Medicine's total equity?
- Prime Medicine (PRME) reported total equity of $39.81M in Q2 2026.
- How has Prime Medicine's total equity changed year-over-year?
- Prime Medicine's total equity decreased by 34.6% year-over-year, from $60.86M to $39.81M.
- What is the long-term trend for Prime Medicine's total equity?
- Over 5 years (2020 to 2025), Prime Medicine's total equity has grown at a 120.1% compound annual growth rate (CAGR), from $2.34M to $120.87M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Prime Medicine's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude